logo
Select company
Select metric
-0.08%Buyback Yield
VS
Market
38
Sector
71
Industry
85
History
100
$ 1.75Close
$ 0.26 - $ 1.84 52-Week Range
Ticker Information

Ticker

OVID

Company Name

OVID THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

OVID THERAPEUTICS INC - Buyback Yield Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

OVID - Buyback Yield Historical data
DateBuyback YieldMarket CapitalizationNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025-0.08%$ 61.01M$ 51K
3/31/2025-2%$ 20.34M$ 407K
12/31/2024-1.79%$ 34.83M$ 622K
9/30/2024-0.74%$ 88.05M$ 655.39K
6/30/2024-1.35%$ 62.31M$ 841.11K
3/31/2024-0.3%$ 229.15M$ 696.21K
12/31/2023-0.25%$ 217.79M$ 535.2K
9/30/2023-0.18%$ 252.33M$ 458.21K
6/30/2023-0.13%$ 247.11M$ 316.12K
3/31/2023-0.08%$ 255.99M$ 214.57K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • OVID THERAPEUTICS INC's latest trailing twelve months (TTM) Buyback Yield stands at -26.97%.
  • Over the past 5 years, OVID THERAPEUTICS INC's average Buyback Yield has been -4.65%.
  • The median Buyback Yield for OVID THERAPEUTICS INC during this period was -0.41%
  • OVID THERAPEUTICS INC reached its highest Buyback Yield over the past 5 years at -0.08%.
  • The lowest Buyback Yield recorded by OVID THERAPEUTICS INC in the same timeframe -26.97%

OVID THERAPEUTICS INC's Buyback Yield vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Buyback Yield Benchmarks
CompanyBuyback Yield
VERU : VERU INC 0%CUE : CUE BIOPHARMA INC -48.9%PSTV : PLUS THERAPEUTICS INC -33.08%CBUS : CIBUS INC 0%TCRX : TSCAN THERAPEUTICS INC -1.9%CRVO : CERVOMED INC 0.01%ALGS : ALIGOS THERAPEUTICS INC -205.65%PYXS : PYXIS ONCOLOGY INC -2.44%NTRB : NUTRIBAND INC -7.12%ARMP : ARMATA PHARMACEUTICALS INC 0%

Definition of Buyback Yield

[Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for OVID THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 103.32M ]) / Market Cap [ $ 383.15M ]
(=) Buyback Yield [ -26.97% ]

OVID - Buyback Yield, Last 5 years

-26.97%

Minimum

Sep 30, 2020

-0.08%

Maximum

Jun 30, 2025

-4.65%

Average

-0.41%

Median

Buyback Yield Benchmark Analysis

The chart above depicts the distribution of Buyback Yield for companies in the Total Stock Market. The average Buyback Yield of the companies is 0.64% with a standard deviation of 2.71%.
The following table provides additional summary stats:
Buyback Yield in the Market:
filtered constituents3.28K
min-8.43%
max8.43%
average0.64%
median0.01%
std2.71%